Skip to main content
Premium Trial:

Request an Annual Quote

Hayden Jeffreys, Joanne Mason

Cambridge Epigenetix has appointed Hayden Jeffreys as chief operating officer and Joanne Mason as vice president of biomarker discovery. Jeffreys has previously served as interim CEO of Erba Diagnostics, as well as head of corporate business development and strategy for Erba Mannheim and Lumora. He has also held senior positions at Lab21 and Gen-Probe (now part of Hologic).

Mason was previously director of sequencing and sample acquisition for Genomics England, where she managed sample collection and sequencing for the 100,000 Genomes Project. She also set up and managed an NGS core facility at Oxford University Hospitals NHS Foundation Trust. She holds a PhD from the University of Cambridge and sits on the MHRA Genomics for Diagnosis Forum, UK NEQAS for molecular genetics DNA extraction steering committee, and Genomics England sequencing advisory board.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.